Petrou Stavros, Rivero-Arias Oliver, Dakin Helen, Longworth Louise, Oppe Mark, Froud Robert, Gray Alastair
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Pharmacoeconomics. 2015 Oct;33(10):985-91. doi: 10.1007/s40273-015-0319-2.
'Mapping' onto generic preference-based outcome measures is increasingly being used as a means of generating health utilities for use within health economic evaluations. Despite the publication of technical guides for the conduct of mapping research, guidance for the reporting of mapping studies is currently lacking. The MAPS (MApping onto Preference-based measures reporting Standards) statement is a new checklist, which aims to promote complete and transparent reporting of mapping studies. The primary audiences for the MAPS statement are researchers reporting mapping studies, the funders of the research, and peer reviewers and editors involved in assessing mapping studies for publication. A de novo list of 29 candidate reporting items and accompanying explanations was created by a working group comprising six health economists and one Delphi methodologist. Following a two-round modified Delphi survey with representatives from academia, consultancy, health technology assessment agencies and the biomedical journal editorial community, a final set of 23 items deemed essential for transparent reporting, and accompanying explanations, was developed. The items are contained in a user-friendly 23-item checklist. They are presented numerically and categorised within six sections, namely: (1) title and abstract; (2) introduction; (3) methods; (4) results; (5) discussion; and (6) other. The MAPS statement is best applied in conjunction with the accompanying MAPS explanation and elaboration document. It is anticipated that the MAPS statement will improve the clarity, transparency and completeness of reporting of mapping studies. To facilitate dissemination and uptake, the MAPS statement is being co-published by seven health economics and quality-of-life journals, and broader endorsement is encouraged. The MAPS working group plans to assess the need for an update of the reporting checklist in 5 years' time.
映射到基于通用偏好的结果测量指标正越来越多地被用作生成健康效用值的一种方法，以便用于卫生经济评估。尽管已经发布了开展映射研究的技术指南，但目前缺乏关于报告映射研究的指导。MAPS（映射到基于偏好的测量指标报告标准）声明是一份新的清单，旨在促进对映射研究进行完整且透明的报告。MAPS声明的主要受众包括报告映射研究的研究人员、研究资助者以及参与评估映射研究以供发表的同行评审人员和编辑。一个由六名卫生经济学家和一名德尔菲法专家组成的工作组创建了一份包含29个候选报告项目及相应解释的全新清单。在与来自学术界、咨询公司、卫生技术评估机构和生物医学期刊编辑界的代表进行两轮修改后的德尔菲调查后，制定了一套最终的23个被认为对透明报告至关重要的项目及相应解释。这些项目包含在一份用户友好的23项清单中。它们按数字顺序列出，并分为六个部分，即：(1) 标题和摘要；(2) 引言；(3) 方法；(4) 结果；(5) 讨论；以及(6) 其他。MAPS声明最好与随附的MAPS解释与阐述文件一起应用。预计MAPS声明将提高映射研究报告的清晰度、透明度和完整性。为便于传播和采用，MAPS声明由七家卫生经济与生活质量期刊联合发表，并鼓励更广泛的认可。MAPS工作组计划在5年后评估是否需要更新报告清单。
